ES2190470T3 - Cetp para incrementar el nivel de colesterol de las hdl. - Google Patents

Cetp para incrementar el nivel de colesterol de las hdl.

Info

Publication number
ES2190470T3
ES2190470T3 ES96918201T ES96918201T ES2190470T3 ES 2190470 T3 ES2190470 T3 ES 2190470T3 ES 96918201 T ES96918201 T ES 96918201T ES 96918201 T ES96918201 T ES 96918201T ES 2190470 T3 ES2190470 T3 ES 2190470T3
Authority
ES
Spain
Prior art keywords
cetp
hdl
increase
cholesterol level
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96918201T
Other languages
English (en)
Inventor
Deborah Y Kwoh
Steven W Brostoff
Dennis J Carlo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celldex Therapeutics Inc
Original Assignee
Avant Immunotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avant Immunotherapeutics Inc filed Critical Avant Immunotherapeutics Inc
Application granted granted Critical
Publication of ES2190470T3 publication Critical patent/ES2190470T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Ink Jet Recording Methods And Recording Media Thereof (AREA)
  • Color Television Image Signal Generators (AREA)
  • Materials For Photolithography (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA UN METODO PARA AUMENTAR EL COLESTEROL HDL EN UN MAMIFERO ESTIMULANDO UNA RESPUESTA INMUNITARIA QUE INHIBE LA FUNCION DE CETP. DICHA RESPUESTA INMUNITARIA PUEDE SER INDUCIDA INMUNIZANDO CON CETP O FRAGMENTOS DE CETP (DENOMINADOS CONJUNTAMENTE "PEPTIDOS CETP") QUE CONTIENEN UN EPITOPO CAPAZ DE ESTIMULAR DICHA RESPUESTA. LOS PEPTIDOS PUEDEN CONJUGARSE A UN VEHICULO, TAL COMO KLH U OVOALBUMINA, CON EL OBJETIVO DE AUMENTAR LA INMUNOGENICIDAD. PUEDEN ADMINISTRASE ASIMISMO ADYUVANTES.
ES96918201T 1995-06-06 1996-06-05 Cetp para incrementar el nivel de colesterol de las hdl. Expired - Lifetime ES2190470T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48245495A 1995-06-06 1995-06-06

Publications (1)

Publication Number Publication Date
ES2190470T3 true ES2190470T3 (es) 2003-08-01

Family

ID=23916145

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96918201T Expired - Lifetime ES2190470T3 (es) 1995-06-06 1996-06-05 Cetp para incrementar el nivel de colesterol de las hdl.

Country Status (9)

Country Link
US (1) US7074407B1 (es)
EP (1) EP0831881B1 (es)
JP (1) JP3910635B2 (es)
AT (1) ATE234109T1 (es)
CA (1) CA2223177A1 (es)
DE (1) DE69626642T2 (es)
DK (1) DK0831881T3 (es)
ES (1) ES2190470T3 (es)
WO (1) WO1996039168A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410022B1 (en) 1995-05-01 2002-06-25 Avant Immunotherapeutics, Inc. Modulation of cholesteryl ester transfer protein (CETP) activity
DK0831881T3 (da) 1995-06-06 2003-07-07 Avant Immunotherapeutics Inc CETP til forøgelse af HDL-cholesterolniveau
US6284533B1 (en) 1996-05-01 2001-09-04 Avant Immunotherapeutics, Inc. Plasmid-based vaccine for treating atherosclerosis
US6846808B1 (en) 1996-05-01 2005-01-25 Avant Immunotherapeutics, Inc. Plasmid-based vaccine for treating atherosclerosis
EP1024825A1 (en) * 1997-10-20 2000-08-09 Avant Immunotherapeutics, Inc. Xenogeneic cholesteryl ester transfer protein (cetp) for modulation of cetp activity
US6300308B1 (en) * 1997-12-31 2001-10-09 Board Of Regents, The University Of Texas System Methods and compositions for inducing autoimmunity in the treatment of cancers
US7749721B2 (en) * 1999-12-13 2010-07-06 Universidad Nacional Autónoma de México Immuno enzymatic quantification method for cholesterol ester transferring protein (CETP)
MX347400B (es) * 2012-06-29 2017-04-18 Univ Nac Autónoma De México Vacuna de aplicacion nasal contra el desarrollo de la enfermedad aterosclerotica y el higado graso.
TW201627318A (zh) 2014-10-22 2016-08-01 臺北醫學大學 膽固醇酯轉運蛋白抗原肽及其融合蛋白以及其組合物及應用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143305A (en) 1973-05-07 2000-11-07 The Ohio State University Antigenically modified polypeptides composition
US5126399A (en) 1986-04-30 1992-06-30 Board Of Regents, The University Of Texas System Methods and compositions for the preparation and use of site-directed immunologic reagents
US5338829A (en) 1988-04-20 1994-08-16 Trustees Of The University Of Pennsylvania Peptides derived from human immunodeficiency virus-1 GP160
GB8812214D0 (en) 1988-05-24 1988-06-29 Hoffmann La Roche Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope
US5242687A (en) 1989-03-15 1993-09-07 Tkb Associates Limited Partnership Method of reducing cellular immune response involving T-cells using CD8-bearing antigen presenting cells
US5264341A (en) * 1989-08-30 1993-11-23 Eli Lilly And Company Selective cloning for high monoclonal antibody secreting hybridomas
JP3183665B2 (ja) 1990-12-10 2001-07-09 エントルメド インコーポレーテッド コレステロール過剰血症およびアテローム性動脈硬化を防止するためのコレステロールに体するワクチン
WO1993011782A1 (en) * 1991-12-19 1993-06-24 Southwest Foundation For Biomedical Research Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments
AU4377793A (en) 1992-05-20 1993-12-13 Johns Hopkins University, The Alternative receptor therapy
US5279540A (en) 1992-09-24 1994-01-18 Davidson Michael H Method for reducing the risk of atherosclerosis
US5618683A (en) 1993-04-13 1997-04-08 Brocia; Robert W. Diagnostic kit for cholesteryl ester transfer protein (CETP) activity measurement and a new synthetic particle used therein
US5759551A (en) 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
DK0708656T3 (da) 1993-04-27 2002-12-02 United Biomedical Inc Antigene LHRH peptidkonstruktioner og universelle syntetiske immunstimulatorer til vacciner
EP0664813A4 (en) * 1993-08-04 1998-05-27 Southwest Found Biomed Res CETP INHIBITOR POLYPEPTIDE, ANTIBODY AGAINST THE SYNTHETIC POLYPEPTIDE AND PHROPHYLACTIC AND THERAPEUTIC ANTI-ARTERIOSCLEOSIS TREATMENT.
DK96493D0 (da) 1993-08-26 1993-08-26 Mouritsen Og Elsner Aps Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
JPH09501186A (ja) 1994-11-12 1997-02-04 株式会社エルジ化学 コレステリルエステル運搬蛋白質阻害ペプチドおよびこれを含む動脈硬化症のための予防および治療剤
US5705388A (en) 1994-12-23 1998-01-06 Ribozyme Pharmaceuticals, Inc. CETP Ribozymes
US6410022B1 (en) 1995-05-01 2002-06-25 Avant Immunotherapeutics, Inc. Modulation of cholesteryl ester transfer protein (CETP) activity
DK0831881T3 (da) 1995-06-06 2003-07-07 Avant Immunotherapeutics Inc CETP til forøgelse af HDL-cholesterolniveau
JP2001508760A (ja) 1996-05-01 2001-07-03 アヴァント イムノセラピユーティクス，インコーポレーテッド アテローム性動脈硬化症治療用のプラスミド型ワクチン
US6284533B1 (en) 1996-05-01 2001-09-04 Avant Immunotherapeutics, Inc. Plasmid-based vaccine for treating atherosclerosis
US5994310A (en) 1998-09-03 1999-11-30 Bayer Corporation Peptide ligands for affinity purification of human Factor VIII

Also Published As

Publication number Publication date
AU715410B2 (en) 2000-02-03
ATE234109T1 (de) 2003-03-15
JP3910635B2 (ja) 2007-04-25
CA2223177A1 (en) 1996-12-12
EP0831881A1 (en) 1998-04-01
DK0831881T3 (da) 2003-07-07
EP0831881B1 (en) 2003-03-12
DE69626642D1 (de) 2003-04-17
US7074407B1 (en) 2006-07-11
JPH11507910A (ja) 1999-07-13
AU6091296A (en) 1996-12-24
DE69626642T2 (de) 2004-01-29
WO1996039168A1 (en) 1996-12-12

Similar Documents

Publication Publication Date Title
ES2196024T3 (es) Vacunas conjugadas de gangliosido-klh con qs-21.
CO5280094A1 (es) Un analogo de a o app y una composicion inmunogenica que comprende dicho analogo
IL96734A0 (en) Aerosol formulations of autoantigens
ES2157447T3 (es) Composicion de vacuna que comprende un antigeno de polisacarido conjugado adsorbido en fosfato de aluminio.
ES2191016T3 (es) Anticuerpos monoclonales neutralizantes humanos para el virus respiratorio sincitial.
NO984093D0 (no) FremgangsmÕter for lindring av neuropatisk smerte ved bruk av prosaposin-abledete peptider
IL104696A0 (en) Dual carrier immunogenic construct and a vaccine containing the same
IL189629A0 (en) Compositions containing human ctla-4 antibodies
UA40597C2 (uk) Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів
PL314879A1 (en) Sperm antigen corresponding to an autoanitigenic epitope on sperm protein bounded to the transparent tunica
ES2164251T3 (es) Vacuna que comprende un conjugado antigeno polisacarido-proteina transportadora y proteina transportadora libre.
ES2190470T3 (es) Cetp para incrementar el nivel de colesterol de las hdl.
ES2137498T3 (es) Inmunogenos contra la hormona liberadora de gonadotropinas.
EP1007556A4 (en) TROPONIN SUB-UNITS AND FRAGMENTS FOR USE AS INHIBITORS OF ANGIOGENESIS
MY113428A (en) Hepatitis b vaccine
BR9707819A (pt) Imunogenos peptidicos
ES2195169T3 (es) Vacunas contra calmidias y composiciones inmunogenicas que contienen un antigeno de membrana externa y metodos para su preparacion.
AU1311492A (en) Progressive ophthalmic lens
EP0716613A4 (en) TREATING A GASTRODUODENAL DISEASE CAUSED BY -i (HELICOBAKTER PYLORI)
ZA972757B (en) Porphyromonas gingivalis antigents for the diagnosis and treatment of periodontitis.
ES2069099T3 (es) Vacuna recombinante para la pleuroneumonia porcina.
MX9301675A (es) Composiciones que contienen peptidos para inducir tolerancia de las celulas t a un antigeno.
PT782630E (pt) Gene da doenca poliquistica do rim
ATE329615T1 (de) Borrelia burgdorferi bacterin
FR2719998B1 (fr) Composition immunisante anti-hélicobacter pylori à base de catalase.